24
Participants
Start Date
March 10, 2020
Primary Completion Date
May 1, 2021
Study Completion Date
May 1, 2021
Dextrose
Administering dextrose to healthy volunteers for our placebo group
Dronabinol
THC (Marinol® \[dronabinol\]; Solvay Pharmaceuticals) will be orally administered in doses of 7.5 mg and 15 mg, in opaque capsules with dextrose filler. Placebo capsules contain only dextrose. These doses of THC are known to produce performance impairments as well as subjective intoxication with little to no adverse reactions in experienced occasional, but non-daily cannabis users.
Dronabinol
THC (Marinol® \[dronabinol\]; Solvay Pharmaceuticals) will be orally administered in doses of 7.5 mg and 15 mg, in opaque capsules with dextrose filler. Placebo capsules contain only dextrose. These doses of THC are known to produce performance impairments as well as subjective intoxication with little to no adverse reactions in experienced occasional, but non-daily cannabis users.
University of Chicago Hospital, Chicago
University of Chicago, Chicago
University of Chicago
OTHER